Most people take fish oil hoping it protects their brain. But whether it actually does comes down to three things: which omega-3 you’re getting, your genes, and when you start.
The randomized trials and the real world studies look like they completely disagree. They don’t. Below are the written takeaways as always, plus a short video version if you’d rather watch.
Key points
Fish oil for the brain isn’t one size fits all. Whether it helps comes down to three things: the type of omega-3, your genes, and your timing.
DHA builds, EPA calms. DHA is the builder, the structural fat your brain is largely made of and EPA is the peacekeeper, the one that calms inflammation.
The trials disagree for a reason. Randomized trials often show no benefit, while real world studies show roughly 20% lower dementia risk. Both are right. It comes down to who was studied, for how long, and when they started.
One gene changes everything: APOE e4. Carriers face 3 to 5 times higher Alzheimer’s risk and burn through DHA faster. As a result, carriers may have chronically low DHA even on a normal diet. Timing matters most so supplementing early is important.
Who should pay closest attention:
APOE e4 carriers, or anyone with a strong family history of Alzheimer’s
People who rarely eat oily fish
Anyone whose Omega-3 Index tests low
Know your number. The Omega-3 Index is a simple blood test with a target zone of roughly 8 to 11%. It is the most direct way to know whether what you’re taking is actually working. Remember too that omega-3 is one leg of the stool; it works alongside the other pillars of brain health, not instead of them.
Bottom line: If you carry APOE e4 or have a family history, start early and test your Omega-3 Index rather than guessing.
Watch the video
This video is for general education only and isn’t medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication, especially if you take a blood thinner or have a bleeding risk.
If you have found this helpful, please share and subscribe.
References
Wei et al., Am J Clin Nutr 2023. von Schacky, Nutrients 2021. Zhang et al., Prog Lipid Res 2024. Ebright et al., Trends Endocrinol Metab 2024. Li et al., Eur J Neurol 2022. Rouch et al., Am J Clin Nutr 2022. Gebauer et al., Am J Clin Nutr 2006. Shahinfar et al., Sci Rep 2025. Coley et al., J Nutr Health Aging 2018. Welty et al., Arterioscler Thromb Vasc Biol 2024. Morris et al., JAMA 2016. Calder et al., Nutr Res Rev 2025. Scarmeas et al., Lancet Neurol 2018. Lewis et al., Nutr Res Rev 2025.